CN107674003B - Tetrahydroxy-modified diurea compounds and their gels and gel-based methods for detecting mercury ions - Google Patents
Tetrahydroxy-modified diurea compounds and their gels and gel-based methods for detecting mercury ions Download PDFInfo
- Publication number
- CN107674003B CN107674003B CN201710832006.9A CN201710832006A CN107674003B CN 107674003 B CN107674003 B CN 107674003B CN 201710832006 A CN201710832006 A CN 201710832006A CN 107674003 B CN107674003 B CN 107674003B
- Authority
- CN
- China
- Prior art keywords
- gel
- tetrahydroxy
- modified
- mercury ions
- dimethyl sulfoxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- -1 mercury ions Chemical class 0.000 title claims abstract description 73
- 229910052753 mercury Inorganic materials 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims abstract description 23
- 239000000499 gel Substances 0.000 title description 72
- XMKLTEGSALONPH-UHFFFAOYSA-N 1,2,4,5-tetrazinane-3,6-dione Chemical class O=C1NNC(=O)NN1 XMKLTEGSALONPH-UHFFFAOYSA-N 0.000 title description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims abstract description 106
- 230000002441 reversible effect Effects 0.000 claims abstract description 41
- 229910052737 gold Inorganic materials 0.000 claims abstract description 21
- 239000010931 gold Substances 0.000 claims abstract description 21
- 239000002253 acid Substances 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000000243 solution Substances 0.000 claims description 36
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 27
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims description 23
- 239000004327 boric acid Substances 0.000 claims description 23
- 239000007864 aqueous solution Substances 0.000 claims description 19
- VDZOOKBUILJEDG-UHFFFAOYSA-M tetrabutylammonium hydroxide Chemical compound [OH-].CCCC[N+](CCCC)(CCCC)CCCC VDZOOKBUILJEDG-UHFFFAOYSA-M 0.000 claims description 18
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical group [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 13
- 238000010521 absorption reaction Methods 0.000 claims description 13
- 239000000523 sample Substances 0.000 claims description 11
- BQPIGGFYSBELGY-UHFFFAOYSA-N mercury(2+) Chemical compound [Hg+2] BQPIGGFYSBELGY-UHFFFAOYSA-N 0.000 claims description 10
- 239000002131 composite material Substances 0.000 claims description 9
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 8
- 239000002245 particle Substances 0.000 claims description 7
- 238000000870 ultraviolet spectroscopy Methods 0.000 claims description 7
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims description 4
- 239000011259 mixed solution Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 3
- 239000012498 ultrapure water Substances 0.000 claims description 3
- 239000012488 sample solution Substances 0.000 claims description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 abstract description 15
- 239000002105 nanoparticle Substances 0.000 abstract description 12
- 150000001875 compounds Chemical class 0.000 abstract description 9
- 230000035945 sensitivity Effects 0.000 abstract description 6
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 abstract description 5
- 239000001257 hydrogen Substances 0.000 abstract description 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 3
- 239000012046 mixed solvent Substances 0.000 abstract description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea group Chemical group NC(=O)N XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract description 3
- 239000002114 nanocomposite Substances 0.000 abstract 1
- 238000001514 detection method Methods 0.000 description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 230000008859 change Effects 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 6
- 238000005481 NMR spectroscopy Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 4
- 229910021645 metal ion Inorganic materials 0.000 description 4
- KJJPLEZQSCZCKE-UHFFFAOYSA-N 2-aminopropane-1,3-diol Chemical compound OCC(N)CO KJJPLEZQSCZCKE-UHFFFAOYSA-N 0.000 description 3
- 238000001479 atomic absorption spectroscopy Methods 0.000 description 3
- 238000001391 atomic fluorescence spectroscopy Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000001095 inductively coupled plasma mass spectrometry Methods 0.000 description 3
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 3
- 230000009974 thixotropic effect Effects 0.000 description 3
- ICLCCFKUSALICQ-UHFFFAOYSA-N 1-isocyanato-4-(4-isocyanato-3-methylphenyl)-2-methylbenzene Chemical group C1=C(N=C=O)C(C)=CC(C=2C=C(C)C(N=C=O)=CC=2)=C1 ICLCCFKUSALICQ-UHFFFAOYSA-N 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 2
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 2
- 229910001422 barium ion Inorganic materials 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- WLZRMCYVCSSEQC-UHFFFAOYSA-N cadmium(2+) Chemical compound [Cd+2] WLZRMCYVCSSEQC-UHFFFAOYSA-N 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 229910001430 chromium ion Inorganic materials 0.000 description 2
- 229910001429 cobalt ion Inorganic materials 0.000 description 2
- XLJKHNWPARRRJB-UHFFFAOYSA-N cobalt(2+) Chemical compound [Co+2] XLJKHNWPARRRJB-UHFFFAOYSA-N 0.000 description 2
- 229910001431 copper ion Inorganic materials 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 125000005442 diisocyanate group Chemical group 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- RVPVRDXYQKGNMQ-UHFFFAOYSA-N lead(2+) Chemical compound [Pb+2] RVPVRDXYQKGNMQ-UHFFFAOYSA-N 0.000 description 2
- 229910001425 magnesium ion Inorganic materials 0.000 description 2
- 229910001453 nickel ion Inorganic materials 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- ULUZGMIUTMRARO-UHFFFAOYSA-N (carbamoylamino)urea Chemical class NC(=O)NNC(N)=O ULUZGMIUTMRARO-UHFFFAOYSA-N 0.000 description 1
- ALQLPWJFHRMHIU-UHFFFAOYSA-N 1,4-diisocyanatobenzene Chemical compound O=C=NC1=CC=C(N=C=O)C=C1 ALQLPWJFHRMHIU-UHFFFAOYSA-N 0.000 description 1
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 1
- 206010007269 Carcinogenicity Diseases 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 231100000260 carcinogenicity Toxicity 0.000 description 1
- 230000007670 carcinogenicity Effects 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 229920000547 conjugated polymer Polymers 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229960002523 mercuric chloride Drugs 0.000 description 1
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010850 salt effect Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002910 solid waste Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- AMCYFOSVYJWEBU-UHFFFAOYSA-N tetrabutylazanium borate Chemical compound [O-]B([O-])[O-].CCCC[N+](CCCC)(CCCC)CCCC.CCCC[N+](CCCC)(CCCC)CCCC.CCCC[N+](CCCC)(CCCC)CCCC AMCYFOSVYJWEBU-UHFFFAOYSA-N 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- RIUWBIIVUYSTCN-UHFFFAOYSA-N trilithium borate Chemical compound [Li+].[Li+].[Li+].[O-]B([O-])[O-] RIUWBIIVUYSTCN-UHFFFAOYSA-N 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/0052—Preparation of gels
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/0052—Preparation of gels
- B01J13/0056—Preparation of gels containing inorganic material and water
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/38—Diluting, dispersing or mixing samples
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Dispersion Chemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Health & Medical Sciences (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明公开了一种四羟基修饰的双脲类化合物及其凝胶和基于凝胶检测汞离子的方法,该化合物的结构式为
式中R代表该化合物与硼酸盐在二甲亚砜与水的混合溶剂中通过硼氧键和脲基之间的氢键可形成可逆共价键凝胶,以形成的凝胶为基质,通过原位还原氯金酸制备金纳米颗粒,所得的凝胶和纳米金复合物可以高灵敏度、高选择性检测汞离子,且具有耗时短、成本低、操作简单等优点。The invention discloses a tetrahydroxy-modified diurea compound, its gel and a method for detecting mercury ions based on the gel. The compound has the following structural formula:
where R stands for The compound and borate in the mixed solvent of dimethyl sulfoxide and water can form a reversible covalent bond gel through the hydrogen bond between the boron-oxygen bond and the urea group. Gold nanoparticles are prepared from chloroauric acid, and the resulting gel and gold nanocomposite can detect mercury ions with high sensitivity and selectivity, and have the advantages of short time consumption, low cost, and simple operation.Description
技术领域technical field
本发明属于汞离子检测技术领域,具体涉及一种四羟基修饰的双脲类化合物,以及采用该化合物制备的可逆共价键分子凝胶和基于该凝胶检测汞离子的方法。The invention belongs to the technical field of mercury ion detection, in particular to a tetrahydroxy-modified diurea compound, a reversible covalent bond molecular gel prepared by using the compound, and a method for detecting mercury ions based on the gel.
背景技术Background technique
有毒的金属离子对人类的健康和环境有着非常严重的影响,因此,检测水生态系统中这些污染物成为人们关注的焦点。汞是环境中最有害的有毒金属离子之一,一般通过煤的燃烧、电厂、海洋、火山喷发、金矿和固体垃圾的焚烧等途径产生。汞离子(Hg2+)最稳定的形式是形成无机汞,它具有腐蚀性和致癌性等高细胞毒性,它能够使大脑、神经系统、肾脏以及内分泌系统受到严重损害,长期接触无机汞会引起自身免疫系统的疾病。因此,对环境和生物样品中汞离子进行高灵敏度和高选择性的检测有着非常重要意义。目前,常用的检测Hg2+的方法主要有原子吸收光谱法(Atomic absorption spectrometry,AAS),原子荧光光谱法(Atomic fluorescence spectrometry,AFS),电感耦合等离子体质谱法(Inductively oupled plasma mass spectrometry,ICPMS)和高效液相色谱法(High-performance liquid chromatography,HPLC)等。虽然这些方法有很多优点,但是,它们通常需要昂贵的仪器设备,样品的制备过程繁琐,需要对样品进行分离和富集,从而需要大量的时间。因此,建立一种高灵敏度、高选择性、耗时短、成本低的测定Hg2+的方法成为当今研究的热点。光学传感器不需要特殊的仪器,还可以对Hg2+进行可视化检测,引起人们的广泛关注。如今,提出了基于有机发色团和荧光基团、共轭聚合物、核酸、DNA酶、蛋白、薄膜以及纳米粒子的Hg2+传感器。虽然这些光学传感器要比传统方法简单很多,但大多数的灵敏度和选择性低,探针材料的合成步骤繁杂,或不适合实际样品的检验,使其应用受到了很大的限制。因此,设计一种不仅灵敏度和选择性高,而且简单、经济、实用的检测Hg2+的方法仍然是目前研究的前沿热点。Toxic metal ions have a very serious impact on human health and the environment. Therefore, the detection of these pollutants in water ecosystems has become the focus of attention. Mercury is one of the most harmful toxic metal ions in the environment. It is generally produced through the combustion of coal, power plants, oceans, volcanic eruptions, gold mines and the incineration of solid waste. The most stable form of mercury ion (Hg 2+ ) is the formation of inorganic mercury, which has high cytotoxicity such as corrosiveness and carcinogenicity. It can seriously damage the brain, nervous system, kidney and endocrine system. Long-term exposure to inorganic mercury can cause Diseases of the autoimmune system. Therefore, it is of great significance to detect mercury ions with high sensitivity and selectivity in environmental and biological samples. At present, the commonly used detection methods for Hg 2+ mainly include atomic absorption spectrometry (Atomic absorption spectrometry, AAS), atomic fluorescence spectrometry (Atomic fluorescence spectrometry, AFS), inductively coupled plasma mass spectrometry (Inductively coupled plasma mass spectrometry, ICPMS) ) and high-performance liquid chromatography (High-performance liquid chromatography, HPLC). Although these methods have many advantages, they usually require expensive equipment, cumbersome sample preparation, and the need to separate and enrich the samples, thus requiring a lot of time. Therefore, establishing a method for the determination of Hg 2+ with high sensitivity, high selectivity, short time-consuming and low cost has become a hot research topic. Optical sensors do not require special instruments and can also visually detect Hg 2+ , which has attracted widespread attention. Today, Hg sensors based on organic chromophores and fluorophores, conjugated polymers, nucleic acids, DNases, proteins, thin films, and nanoparticles have been proposed. Although these optical sensors are much simpler than traditional methods, most of them have low sensitivity and selectivity, complicated synthesis steps of probe materials, or are not suitable for the inspection of actual samples, so their applications are greatly limited. Therefore, designing a simple, economical and practical method for the detection of Hg 2+ not only with high sensitivity and selectivity is still a frontier research hotspot.
发明内容SUMMARY OF THE INVENTION
本发明所要解决的技术问题在于提供一种四羟基修饰的双脲类化合物,以及基于该化合物的可逆共价键分子凝胶和以该凝胶为基质检测汞离子的方法。The technical problem to be solved by the present invention is to provide a tetrahydroxy-modified diurea compound, a reversible covalent bond molecular gel based on the compound, and a method for detecting mercury ions using the gel as a matrix.
解决上述技术问题所采用的四羟基修饰的双脲类化合物的结构式如下所示:The structural formula of the tetrahydroxy-modified diurea compound used to solve the above-mentioned technical problems is as follows:
式中R代表 where R stands for
上述四羟基修饰的双脲类化合物的制备方法为:将2-氨基-1,3-丙二醇溶于甲醇中,将式I所示的二异氰酸酯的二氯甲烷溶液逐滴加入上述溶液中,其中2-氨基-1,3-丙二醇与二异氰酸酯的摩尔比为2:1;甲醇与二氯甲烷的体积比为1:75,常温搅拌反应16小时,过滤,用乙酸乙酯洗涤,干燥,得到四羟基修饰的双脲类化合物,具体合成路线如下:The preparation method of the above-mentioned tetrahydroxy-modified diurea compound is as follows: 2-amino-1,3-propanediol is dissolved in methanol, and the dichloromethane solution of the diisocyanate shown in formula I is added dropwise to the above solution, wherein The molar ratio of 2-amino-1,3-propanediol to diisocyanate is 2:1; the volume ratio of methanol to dichloromethane is 1:75, the reaction is stirred at room temperature for 16 hours, filtered, washed with ethyl acetate, and dried to obtain Four hydroxyl modified diurea compounds, the specific synthetic route is as follows:
本发明的可逆共价键分子凝胶是由上述的四羟基修饰的双脲类化合物与硼酸盐在二甲亚砜与水的混合溶剂中通过可逆硼氧键和脲基之间的氢键形成,其中硼酸盐为硼酸锂、硼酸钠、四丁基硼酸铵中的任意一种,所述的硼酸盐是由硼酸和氢氧化物反应生成,其中所述的氢氧化物为氢氧化锂、氢氧化钠或四丁基氢氧化铵。The reversible covalent bond molecular gel of the present invention is a hydrogen bond between the above-mentioned tetrahydroxy-modified diurea compound and borate in a mixed solvent of dimethyl sulfoxide and water through a reversible boron-oxygen bond and a urea group Form, wherein borate is any one in lithium borate, sodium borate, tetrabutylammonium borate, and described borate is generated by boric acid and hydroxide reaction, and wherein said hydroxide is hydroxide Lithium, sodium hydroxide or tetrabutylammonium hydroxide.
上述可逆共价键分子凝胶的制备方法为:将四羟基修饰的双脲类化合物和硼酸完全溶解于二甲亚砜中,然后加入氢氧化物的水溶液,混合均匀,所得混合液常温静置10~20分钟,得到可逆共价键分子凝胶。The preparation method of the above-mentioned reversible covalent bond molecular gel is as follows: the tetrahydroxy-modified diurea compound and boric acid are completely dissolved in dimethyl sulfoxide, then an aqueous solution of hydroxide is added, and the mixture is uniformly mixed, and the obtained mixed solution is allowed to stand at room temperature After 10-20 minutes, a reversible covalent bond molecular gel is obtained.
上述可逆共价键分子凝胶的制备方法中,所述的四羟基修饰的双脲类化合物、硼酸、氢氧化物的摩尔比为1:1:1,且混合液中四羟基修饰的双脲类化合物的浓度为0.018~0.050g/mL;所述的二甲亚砜与水的体积比为7:3~9:1。In the preparation method of the above-mentioned reversible covalent bond molecular gel, the molar ratio of the tetrahydroxy-modified biurea compound, boric acid and hydroxide is 1:1:1, and the tetrahydroxy-modified biurea in the mixed solution The concentration of the compound is 0.018-0.050 g/mL; the volume ratio of the dimethyl sulfoxide to water is 7:3-9:1.
基于本发明可逆共价键分子凝胶检测汞离子的方法由下述步骤组成:The method for detecting mercury ions based on the reversible covalent bond molecular gel of the present invention consists of the following steps:
1、将四羟基修饰的双脲类化合物和硼酸完全溶解于二甲亚砜中,然后加入含氢氧化物和氯金酸的水溶液,混合均匀,常温避光静置10~20分钟,得到含有氯金酸的无色凝胶。1. Completely dissolve the tetrahydroxy-modified biurea compound and boric acid in dimethyl sulfoxide, then add an aqueous solution containing hydroxide and chloroauric acid, mix evenly, and let stand in the dark at room temperature for 10 to 20 minutes to obtain a solution containing Colorless gel of chloroauric acid.
2、在含有氯金酸的无色凝胶上加入水合肼的无水乙醇溶液,在密封条件下避光放置12~48小时,得到含有纳米金颗粒的凝胶。2. Add anhydrous ethanol solution of hydrazine hydrate on the colorless gel containing chloroauric acid, and place under sealing conditions in the dark for 12-48 hours to obtain a gel containing gold nanoparticles.
3、在含有纳米金颗粒的凝胶上加入超纯水将凝胶破坏,然后加入二甲亚砜使溶液澄清透明,得到凝胶和纳米金的复合溶液,采用紫外-可见分光光度计测定该复合溶液的表面等离子共振吸收峰λ0,再加入不同浓度的汞离子标准样品溶液,采用紫外-可见分光光度计测定不同浓度汞离子对应体系的表面等离子共振吸收峰λ,并绘制Δλ随汞离子浓度变化的标准曲线,其中Δλ=λ0-λ。3. Add ultrapure water to the gel containing gold nanoparticles to destroy the gel, and then add dimethyl sulfoxide to make the solution clear and transparent to obtain a composite solution of gel and gold nanoparticles. The surface plasmon resonance absorption peak λ 0 of the composite solution was added to the standard sample solution of mercury ions with different concentrations, and the surface plasmon resonance absorption peak λ of the corresponding system with different concentrations of mercury ions was measured by ultraviolet-visible spectrophotometer, and Δλ was plotted with mercury ions. Standard curve of concentration change, where Δλ = λ 0 -λ.
4、按照上述步骤3的方法用紫外-可见分光光度计测量待测样品对应体系的表面等离子共振吸收峰λ,根据公式Δλ=λ0-λ,计算待测样品对应的Δλ,结合标准曲线的线性方程即可高选择性识别汞离子并确定待测样品中汞离子的浓度。4. According to the method of
上述步骤1中,所述含有氯金酸的无色凝胶中氯金酸的浓度为0.5~2.0mmol/L。In the above step 1, the concentration of chloroauric acid in the colorless gel containing chloroauric acid is 0.5-2.0 mmol/L.
与现有技术相比,本发明具有以下有益效果:Compared with the prior art, the present invention has the following beneficial effects:
1、本发明四羟基修饰的双脲类化合物合成步骤简单,产率高,且该化合物与硼酸盐在二甲亚砜与水的混合溶剂中通过硼氧键和脲基之间的氢键可形成可逆共价键凝胶,以形成的凝胶为基质,通过原位还原氯金酸制备金纳米颗粒,该凝胶的三维网络结构可防止纳米金颗粒发生团聚,制得的纳米金颗粒稳定性好,尺寸均匀,分散性好,平均粒径为20~30nm,且凝胶与纳米金颗粒的相容性较好,纳米金对成胶速度和成胶情况不会造成很大的影响。1. The tetrahydroxy-modified diurea compound of the present invention has simple synthesis steps and high yield, and the compound and borate pass through the hydrogen bond between boron-oxygen bond and urea group in a mixed solvent of dimethyl sulfoxide and water A reversible covalent bond gel can be formed, and gold nanoparticles are prepared by in-situ reduction of chloroauric acid with the formed gel as a matrix. The three-dimensional network structure of the gel can prevent the agglomeration of gold nanoparticles, and the prepared gold nanoparticles Good stability, uniform size, good dispersibility, the average particle size is 20-30nm, and the gel has good compatibility with gold nanoparticles. .
2、本发明的可逆共价键凝胶和纳米金形成的复合溶液可以实现汞离子的高灵敏度、高选择性检测,检测耗时短、成本低,且复合溶液中纳米金颗粒不易发生团聚,稳定性好,对汞离子的检测带来了极大的方便,对环境和生物样品中汞离子进行高灵敏度和高选择性的检测有着非常重要意义。本发明获得了中国国家自然科学基金(基金号为21473110)的支持。2. The composite solution formed by the reversible covalent bond gel and the nano-gold of the present invention can realize the high-sensitivity and high-selectivity detection of mercury ions, the detection time is short, the cost is low, and the nano-gold particles in the composite solution are not easy to agglomerate. It has good stability and brings great convenience to the detection of mercury ions. It is of great significance to detect mercury ions in environmental and biological samples with high sensitivity and high selectivity. The present invention is supported by the National Natural Science Foundation of China (fund number 21473110).
附图说明Description of drawings
图1是实施例4~12中形成的可逆共价键分子凝胶的照片。FIG. 1 is a photograph of the reversible covalently bonded molecular gels formed in Examples 4-12.
图2是实施例7~9中形成的可逆共价键分子凝胶的应力扫描曲线。2 is the stress sweep curve of the reversible covalently bonded molecular gel formed in Examples 7-9.
图3是实施例7中形成的可逆共价键分子凝胶的触变性行为曲线。FIG. 3 is a thixotropic behavior curve of the reversible covalently bonded molecular gel formed in Example 7. FIG.
图4是实施例8中形成的可逆共价键分子凝胶的的触变性行为曲线。FIG. 4 is the thixotropic behavior curve of the reversible covalent bond molecular gel formed in Example 8. FIG.
图5是实施例9中形成的可逆共价键分子凝胶的触变性行为曲线。FIG. 5 is a thixotropic behavior curve of the reversible covalently bonded molecular gel formed in Example 9. FIG.
图6是实施例9、13、14中形成的可逆共价键分子凝胶的应力扫描曲线。6 is a stress sweep curve of the reversible covalently bonded molecular gels formed in Examples 9, 13, and 14. FIG.
图7是实施例9、15、16中形成的可逆共价键分子凝胶的应力扫描曲线。7 is a stress sweep curve of the reversible covalently bonded molecular gels formed in Examples 9, 15, and 16. FIG.
图8是实施例17中含有纳米金颗粒的凝胶中分离出来的金颗粒的透射电镜图。FIG. 8 is a transmission electron microscope image of gold particles separated from the gel containing gold nanoparticles in Example 17. FIG.
图9是基于实施例8的可逆共价键分子凝胶为基质检测不同浓度汞离子的紫外吸收光谱图。FIG. 9 is an ultraviolet absorption spectrogram of detecting mercury ions with different concentrations based on the reversible covalent bond molecular gel of Example 8 as a matrix.
图10是实施例17中复合溶液的表面等离子共振吸收峰的变化值Δλ随汞离子浓度变化的标准曲线。10 is a standard curve of the change value Δλ of the surface plasmon resonance absorption peak of the composite solution in Example 17 as a function of the mercury ion concentration.
图11是四羟基修饰的双脲类化合物b、硼酸、氢氧化钠对汞离子检测结果的影响。Figure 11 shows the effects of tetrahydroxy-modified diurea compound b, boric acid and sodium hydroxide on the detection results of mercury ions.
图12是采用实施例17的方法检测环境中的不同金属离子的照片。FIG. 12 is a photograph of using the method of Example 17 to detect different metal ions in the environment.
具体实施方式Detailed ways
下面结合附图和实施例对本发明进一步详细说明,但本发明的保护范围不仅限于这些实施例。The present invention is further described in detail below with reference to the accompanying drawings and embodiments, but the protection scope of the present invention is not limited to these embodiments.
实施例1Example 1
制备结构式如下的四羟基修饰的双脲类化合物aPreparation of tetrahydroxy-modified diurea compound a with the following structural formula
取1.476g(16.20mmol)2-氨基-1,3-丙二醇溶于2mL甲醇中,将150mL含1.524g(8.10mmol)4,4'-二异氰酸基-3,3'-二甲基联苯的二氯甲烷溶液逐滴加入上述溶液中,常温搅拌反应16小时,过滤并用乙酸乙酯洗涤,常温真空干燥,得到四羟基修饰的双脲类化合物a。Dissolve 1.476 g (16.20 mmol) of 2-amino-1,3-propanediol in 2 mL of methanol, and dissolve 150 mL of 1.524 g (8.10 mmol) of 4,4'-diisocyanato-3,3'-dimethyl The dichloromethane solution of biphenyl was added dropwise to the above solution, the reaction was stirred at room temperature for 16 hours, filtered, washed with ethyl acetate, and dried under vacuum at room temperature to obtain the tetrahydroxy-modified biurea compound a.
所得化合物a经1H NMR、FTIR表征确认,具体数据如下:1H NMR(600MHz,DMSO-d6,TMS),δ=2.17-2.28(6H,s,2-CH3),δ=3.40-3.46;3.49-3.55(8H,m,4-CH2-),δ=3.59-3.66(2H,m,2-CH-),δ=4.72-4.76(4H,t,4-OH),δ=6.59-6.66(2H,d,2-NH-),δ=7.32-7.36(2H,d,2-Ph),δ=7.37-7.41(2H,s,2-Ph),δ=7.83-7.88(2H,s,2-NH-),δ=7.91-7.95(2H,d,2-Ph).FTIR(KBr):υ=3312cm-1(O-H),υ=3041cm-1(C-H),υ=2970cm-1(N-H),υ=2883cm-1(C-H),υ=1639cm-1(C=O),υ=1593cm-1(C=C)。The obtained compound a was confirmed by 1 H NMR and FTIR characterization, and the specific data are as follows: 1 H NMR (600MHz, DMSO-d 6 , TMS), δ=2.17-2.28 (6H,s, 2-CH 3 ), δ=3.40- 3.46; 3.49-3.55(8H,m,4-CH 2 -),δ=3.59-3.66(2H,m,2-CH-),δ=4.72-4.76(4H,t,4-OH),δ= 6.59-6.66(2H,d,2-NH-),δ=7.32-7.36(2H,d,2-Ph),δ=7.37-7.41(2H,s,2-Ph),δ=7.83-7.88( 2H,s,2-NH-),δ=7.91-7.95(2H,d,2-Ph).FTIR(KBr):υ=3312cm -1 (OH),υ=3041cm -1 (CH),υ= 2970cm -1 (NH), υ=2883cm -1 (CH), υ=1639cm -1 (C=O), υ=1593cm -1 (C=C).
实施例2Example 2
制备结构式如下的四羟基修饰的双脲类化合物bPreparation of tetrahydroxy-modified biurea compound b with the following structural formula
本实施例中,用等摩尔4,4'-二异氰酸二苯甲烷替换实施例1中的4,4'-二异氰酸基-3,3'-二甲基联苯,其他步骤与实施例1相同,得到四羟基修饰的双脲类化合物b。In this example, 4,4'-diisocyanato-3,3'-dimethylbiphenyl in Example 1 was replaced with
所得化合物b经1H NMR、FTIR表征确认,具体数据如下:1H NMR(600MHz,DMSO-d6,TMS),δ=3.37-3.42;3.45-3.50(8H,m,4-CH2-),δ=3.55-3.61(2H,m,2-CH-),δ=3.72-3.75(2H,s,-CH-),δ=4.69-4.73(4H,t,4-OH),δ=5.79-6.01(2H,d,2-NH-),δ=7.00-7.06(4H,d,2-Ph),δ=7.23-7.29(4H,s,2-Ph),δ=8.50-8.54(4H,d,2-NH-).FTIR(KBr):υ=3380cm-1(O-H),υ=3290cm-1(N-H),υ=3100,3031cm-1(C-H),υ=2876cm-1(C-H),υ=1630cm-1(C=O),υ=1572cm-1(C=C)。The obtained compound b was confirmed by 1 H NMR and FTIR characterization, and the specific data are as follows: 1 H NMR (600MHz, DMSO-d 6 , TMS), δ=3.37-3.42; 3.45-3.50 (8H, m, 4-CH 2 -) ,δ=3.55-3.61(2H,m,2-CH-),δ=3.72-3.75(2H,s,-CH-),δ=4.69-4.73(4H,t,4-OH),δ=5.79 -6.01(2H,d,2-NH-),δ=7.00-7.06(4H,d,2-Ph),δ=7.23-7.29(4H,s,2-Ph),δ=8.50-8.54(4H ,d,2-NH-).FTIR(KBr):υ=3380cm -1 (OH),υ=3290cm -1 (NH),υ=3100,3031cm -1 (CH),υ=2876cm -1 (CH ), υ=1630cm -1 (C=O), υ=1572cm -1 (C=C).
实施例3Example 3
制备结构式如下的四羟基修饰的双脲类化合物cPreparation of tetrahydroxy-modified diurea compound c with the following structural formula
本实施例中,用等摩尔1,4-苯二异氰酸酯替换实施例1中的4,4'-二异氰酸基-3,3'-二甲基联苯,其他步骤与实施例1相同,得到四羟基修饰的双脲类化合物c。In this example, the 4,4'-diisocyanato-3,3'-dimethylbiphenyl in Example 1 was replaced with equimolar 1,4-benzenediisocyanate, and other steps were the same as those in Example 1 , to obtain a tetrahydroxy-modified diurea compound c.
所得化合物b经1H NMR、FTIR表征确认,具体数据如下:1H NMR(600MHz,DMSO-d6,TMS),δ=3.37-3.42;3.46-3.51(8H,m,4-CH2-),δ=3.55-3.61(2H,m,2-CH-),δ=4.68-4.73(4H,t,4-OH),δ=5.92-5.96(2H,d,2-NH-),δ=7.18-7.22(4H,s,2-Ph),δ=8.37-8.43(2H,s,2-NH-).FTIR(KBr):υ=3312cm-1(O-H),υ=3041cm-1(C-H),υ=2974cm-1(N-H),υ=2880cm-1(C-H),υ=1639cm-1(C=O),υ=1579cm-1(C=C)。The obtained compound b was confirmed by 1 H NMR and FTIR characterization, and the specific data are as follows: 1 H NMR (600MHz, DMSO-d 6 , TMS), δ=3.37-3.42; 3.46-3.51 (8H, m, 4-CH 2 -) ,δ=3.55-3.61(2H,m,2-CH-),δ=4.68-4.73(4H,t,4-OH),δ=5.92-5.96(2H,d,2-NH-),δ= 7.18-7.22(4H,s,2-Ph),δ=8.37-8.43(2H,s,2-NH-).FTIR(KBr):υ=3312cm -1 (OH),υ=3041cm -1 (CH ), υ=2974cm -1 (NH), υ=2880cm -1 (CH), υ=1639cm -1 (C=O), υ=1579cm -1 (C=C).
实施例4Example 4
将0.04g(0.090mmol)四羟基修饰的双脲类化合物a溶于344μL二甲亚砜中,超声至溶液澄清,然后加入556μL 0.01g/mL(0.090mmol)硼酸的二甲亚砜溶液和100μL 0.022g/mL(0.090mmol)氢氧化锂水溶液,常温震荡均匀,静置15分钟,即可形成不透明的可逆共价键分子凝胶。Dissolve 0.04 g (0.090 mmol) of tetrahydroxy-modified biurea compound a in 344 μL of dimethyl sulfoxide, sonicate until the solution is clear, then add 556 μL of 0.01 g/mL (0.090 mmol) boric acid in dimethyl sulfoxide and 100 μL of dimethyl sulfoxide. 0.022g/mL (0.090mmol) lithium hydroxide aqueous solution, shake uniformly at room temperature, and stand for 15 minutes to form an opaque reversible covalent bond molecular gel.
实施例5Example 5
将0.04g(0.090mmol)四羟基修饰的双脲类化合物a溶于344μL二甲亚砜中,超声至溶液澄清,然后加入556μL 0.01g/mL(0.090mmol)硼酸的二甲亚砜溶液和100μL 0.036g/mL(0.090mmol)氢氧化钠水溶液,常温震荡均匀,静置15分钟,即可形成无色透明的可逆共价键分子凝胶。Dissolve 0.04 g (0.090 mmol) of tetrahydroxy-modified biurea compound a in 344 μL of dimethyl sulfoxide, sonicate until the solution is clear, then add 556 μL of 0.01 g/mL (0.090 mmol) boric acid in dimethyl sulfoxide and 100 μL of dimethyl sulfoxide. 0.036g/mL (0.090mmol) sodium hydroxide aqueous solution, shake uniformly at room temperature, and stand for 15 minutes to form a colorless and transparent reversible covalent molecular gel.
实施例6Example 6
将0.04g(0.090mmol)四羟基修饰的双脲类化合物a溶于344μL二甲亚砜中,超声至溶液澄清,然后加入556μL 0.01g/mL(0.090mmol)硼酸的二甲亚砜溶液和100μL 0.232g/mL(0.090mmol)四丁基氢氧化铵水溶液,常温震荡均匀,静置15分钟,即可形成不透明的可逆共价键分子凝胶。Dissolve 0.04 g (0.090 mmol) of tetrahydroxy-modified biurea compound a in 344 μL of dimethyl sulfoxide, sonicate until the solution is clear, then add 556 μL of 0.01 g/mL (0.090 mmol) boric acid in dimethyl sulfoxide and 100 μL of dimethyl sulfoxide. 0.232 g/mL (0.090 mmol) tetrabutylammonium hydroxide aqueous solution, shake uniformly at room temperature, and stand for 15 minutes to form an opaque reversible covalent molecular gel.
实施例7Example 7
将0.04g(0.092mmol)四羟基修饰的双脲类化合物b溶于330μL二甲亚砜中,超声至溶液澄清,然后加入570μL 0.01g/mL(0.092mmol)硼酸的二甲亚砜溶液和100μL 0.022g/mL(0.092mmol)氢氧化锂水溶液,常温震荡均匀,静置15分钟,即可形成无色透明的可逆共价键分子凝胶。Dissolve 0.04 g (0.092 mmol) of tetrahydroxy-modified biurea compound b in 330 μL of dimethyl sulfoxide, sonicate until the solution is clear, then add 570 μL of 0.01 g/mL (0.092 mmol) boric acid in dimethyl sulfoxide and 100 μL of dimethyl sulfoxide. 0.022g/mL (0.092mmol) lithium hydroxide aqueous solution, shake uniformly at room temperature, and stand for 15 minutes to form a colorless and transparent reversible covalent bond molecular gel.
实施例8Example 8
将0.04g(0.092mmol)四羟基修饰的双脲类化合物b溶于330μL二甲亚砜中,超声至溶液澄清,然后加入570μL 0.01g/mL(0.092mmol)硼酸的二甲亚砜溶液和100μL 0.037g/mL(0.092mmol)氢氧化钠水溶液,常温震荡均匀,静置15分钟,即可形成无色透明的可逆共价键分子凝胶。Dissolve 0.04 g (0.092 mmol) of tetrahydroxy-modified biurea compound b in 330 μL of dimethyl sulfoxide, sonicate until the solution is clear, then add 570 μL of 0.01 g/mL (0.092 mmol) boric acid in dimethyl sulfoxide and 100 μL of dimethyl sulfoxide. 0.037g/mL (0.092mmol) sodium hydroxide aqueous solution, shake evenly at room temperature, and stand for 15 minutes to form a colorless and transparent reversible covalent molecular gel.
实施例9Example 9
将0.04g(0.092mmol)四羟基修饰的双脲类化合物b溶于330μL二甲亚砜中,超声至溶液澄清,然后加入570μL 0.01g/mL(0.092mmol)硼酸的二甲亚砜溶液和100μL 0.240g/mL(0.092mmol)四丁基氢氧化铵水溶液,常温震荡均匀,静置15分钟,即可形成半透明的可逆共价键分子凝胶。Dissolve 0.04 g (0.092 mmol) of tetrahydroxy-modified biurea compound b in 330 μL of dimethyl sulfoxide, sonicate until the solution is clear, then add 570 μL of 0.01 g/mL (0.092 mmol) boric acid in dimethyl sulfoxide and 100 μL of dimethyl sulfoxide. 0.240 g/mL (0.092 mmol) aqueous solution of tetrabutylammonium hydroxide, shake uniformly at room temperature, and stand for 15 minutes to form a translucent reversible covalent molecular gel.
实施例10Example 10
将0.04g(0.120mmol)四羟基修饰的双脲类化合物c溶于178μL二甲亚砜中,超声至溶液澄清,然后加入722μL 0.01g/mL(0.120mmol)硼酸的二甲亚砜溶液和100μL 0.028g/mL(0.120mmol)氢氧化锂水溶液,常温震荡均匀,静置15分钟,即可形成半透明的可逆共价键分子凝胶。Dissolve 0.04 g (0.120 mmol) of tetrahydroxy-modified biurea compound c in 178 μL of dimethyl sulfoxide, sonicate until the solution is clear, then add 722 μL of 0.01 g/mL (0.120 mmol) boric acid in dimethyl sulfoxide and 100 μL of dimethyl sulfoxide. 0.028g/mL (0.120mmol) lithium hydroxide aqueous solution, shake evenly at room temperature, and stand for 15 minutes to form a translucent reversible covalent bond molecular gel.
实施例11Example 11
将0.04g(0.120mmol)四羟基修饰的双脲类化合物c溶于178μL二甲亚砜中,超声至溶液澄清,然后加入722μL 0.01g/mL(0.120mmol)硼酸的二甲亚砜溶液和100μL 0.048g/mL(0.120mmol)氢氧化钠水溶液,常温震荡均匀,静置15分钟,即可形成无色透明的可逆共价键分子凝胶。Dissolve 0.04 g (0.120 mmol) of tetrahydroxy-modified biurea compound c in 178 μL of dimethyl sulfoxide, sonicate until the solution is clear, then add 722 μL of 0.01 g/mL (0.120 mmol) boric acid in dimethyl sulfoxide and 100 μL of dimethyl sulfoxide. 0.048g/mL (0.120mmol) sodium hydroxide aqueous solution, shake uniformly at room temperature, and stand for 15 minutes to form a colorless and transparent reversible covalent molecular gel.
实施例12Example 12
将0.04g(0.120mmol)四羟基修饰的双脲类化合物c溶于178μL二甲亚砜中,超声至溶液澄清,然后加入722μL 0.01g/mL(0.120mmol)硼酸的二甲亚砜溶液和100μL 0.303g/mL(0.120mmol)四丁基氢氧化铵水溶液,常温震荡均匀,静置15分钟,即可形成半透明的可逆共价键分子凝胶。Dissolve 0.04 g (0.120 mmol) of tetrahydroxy-modified biurea compound c in 178 μL of dimethyl sulfoxide, sonicate until the solution is clear, then add 722 μL of 0.01 g/mL (0.120 mmol) boric acid in dimethyl sulfoxide and 100 μL of dimethyl sulfoxide. 0.303 g/mL (0.120 mmol) tetrabutylammonium hydroxide aqueous solution, shake uniformly at room temperature, and stand for 15 minutes to form a translucent reversible covalent molecular gel.
实施例13Example 13
将0.04g(0.092mmol)四羟基修饰的双脲类化合物b溶于230μL二甲亚砜中,超声至溶液澄清,然后加入570μL 0.01g/mL(0.092mmol)硼酸的二甲亚砜溶液和200μL 0.120g/mL(0.092mmol)四丁基氢氧化铵水溶液,常温震荡均匀,静置15分钟,即可形成透明的可逆共价键分子凝胶。Dissolve 0.04 g (0.092 mmol) of tetrahydroxy-modified biurea compound b in 230 μL of dimethyl sulfoxide, sonicate until the solution is clear, then add 570 μL of 0.01 g/mL (0.092 mmol) boric acid in dimethyl sulfoxide and 200 μL of dimethyl sulfoxide. 0.120 g/mL (0.092 mmol) aqueous solution of tetrabutylammonium hydroxide, shake uniformly at room temperature, and stand for 15 minutes to form a transparent reversible covalent molecular gel.
实施例14Example 14
将0.04g(0.092mmol)四羟基修饰的双脲类化合物b溶于130μL二甲亚砜中,超声至溶液澄清,然后加入570μL 0.01g/mL(0.092mmol)硼酸的二甲亚砜溶液和300μL 0.080g/mL(0.092mmol)四丁基氢氧化铵水溶液,常温震荡均匀,静置30分钟,即可形成透明的可逆共价键分子凝胶。Dissolve 0.04 g (0.092 mmol) of tetrahydroxy-modified biurea compound b in 130 μL of dimethyl sulfoxide, sonicate until the solution is clear, then add 570 μL of 0.01 g/mL (0.092 mmol) boric acid in dimethyl sulfoxide and 300 μL of dimethyl sulfoxide. 0.080g/mL (0.092mmol) aqueous solution of tetrabutylammonium hydroxide, shake evenly at room temperature, and stand for 30 minutes to form a transparent reversible covalent bond molecular gel.
实施例15Example 15
将0.036g(0.083mmol)四羟基修饰的双脲类化合物b溶于387μL二甲亚砜中,超声至溶液澄清,然后加入513μL 0.01g/mL(0.083mmol)硼酸的二甲亚砜溶液和100μL 0.217g/mL(0.083mmol)四丁基氢氧化铵水溶液,常温震荡均匀,静置15分钟,即可形成透明的可逆共价键分子凝胶。Dissolve 0.036 g (0.083 mmol) of tetrahydroxy-modified biurea compound b in 387 μL of dimethyl sulfoxide, sonicate until the solution is clear, then add 513 μL of 0.01 g/mL (0.083 mmol) boric acid in dimethyl sulfoxide and 100 μL of dimethyl sulfoxide. 0.217 g/mL (0.083 mmol) aqueous solution of tetrabutylammonium hydroxide, shake uniformly at room temperature, and stand for 15 minutes to form a transparent reversible covalent molecular gel.
实施例16Example 16
将0.045g(0.104mmol)四羟基修饰的双脲类化合物b溶于256μL二甲亚砜中,超声至溶液澄清,然后加入644μL 0.01g/mL(0.104mmol)硼酸的二甲亚砜溶液和100μL 0.271g/mL(0.104mmol)四丁基氢氧化铵水溶液,常温震荡均匀,静置15分钟,即可形成半透明的可逆共价键分子凝胶。Dissolve 0.045 g (0.104 mmol) of tetrahydroxy-modified biurea compound b in 256 μL of dimethyl sulfoxide, sonicate until the solution is clear, then add 644 μL of 0.01 g/mL (0.104 mmol) boric acid in dimethyl sulfoxide and 100 μL of dimethyl sulfoxide. 0.271 g/mL (0.104 mmol) aqueous solution of tetrabutylammonium hydroxide, shake evenly at room temperature, and stand for 15 minutes to form a translucent reversible covalent molecular gel.
上述实施例4~12形成的可逆共价键分子凝胶的照片如图1所示,发明人研究了盐效应对实施例7~9形成的可逆共价键分子凝胶的力学强度及触变性的影响,结果见图2~5。由图2可见,在低剪切力范围内,实施例7~9形成的可逆共价键分子凝胶的储能模量G′均高于损耗模G″,表现出典型的软固体特性,三种凝胶的弹性模量和屈服应力按实施例8>实施例7>实施例9降低,此外,从图2中还可以看出,当剪切应力高于屈服值时,三种凝胶的G′和G″数值急剧下降,G″均明显高于G′,说明凝胶网络结构在高剪切作用下遭到破坏而表现明显的液态行为。由图3~5的测试结果来看,实施例9中形成的凝胶表现出独特的剪切触变性,体系在破坏与恢复10个作用循环过程中“凝胶-溶胶”相变几乎完全可逆,均保持了分子凝胶原有的粘弹性。而实施例7和8中形成的凝胶它们的“凝胶-溶胶”可逆性呈现出下降的趋势,这可能归因于高剪切力下,两个凝胶会变成碎片。The photos of the reversible covalent bond molecular gels formed by the above examples 4 to 12 are shown in Figure 1. The inventors studied the mechanical strength and thixotropy of the reversible covalent bond molecular gels formed by the salt effect in Examples 7 to 9. The results are shown in Figures 2 to 5. It can be seen from Figure 2 that in the low shear range, the storage modulus G' of the reversible covalent bond molecular gels formed in Examples 7-9 is higher than the loss modulus G", showing typical soft solid properties, The elastic moduli and yield stress of the three gels are decreased according to Example 8 > Example 7 > Example 9. In addition, it can also be seen from Figure 2 that when the shear stress is higher than the yield value, the three gels are The values of G′ and G″ dropped sharply, and G″ was significantly higher than G′, indicating that the gel network structure was damaged under high shear and showed obvious liquid behavior. From the test results in Figures 3 to 5 , the gel formed in Example 9 exhibits a unique shear thixotropy, and the "gel-sol" phase transition of the system is almost completely reversible during the 10 cycles of destruction and recovery, all maintaining the original molecular gel. Viscoelasticity, while the gels formed in Examples 7 and 8 showed a decreasing trend in their "gel-sol" reversibility, which may be attributed to the fact that both gels would break into pieces under high shear forces.
发明人进一步研究了实施例9、13、14中溶剂效应对形成的可逆共价键分子凝胶的流变学性能的影响,结果见图6。从图6中可以得出,二甲亚砜与水的体积比分别为9:1(实施例9)、8:2(实施例13)、7:3(实施例14)时,凝胶的屈服值依次为1778.0Pa、891.2Pa、630.9Pa,而凝胶的G′和G″未发生明显变化。该结果表明:溶剂的微小改变将导致凝胶力学强度的显著变化。The inventors further studied the effect of solvent effects on the rheological properties of the formed reversible covalently bonded molecular gels in Examples 9, 13 and 14, and the results are shown in Figure 6 . It can be concluded from Figure 6 that when the volume ratio of dimethyl sulfoxide and water is 9:1 (Example 9), 8:2 (Example 13), and 7:3 (Example 14), respectively, the gel The yield values were 1778.0Pa, 891.2Pa, and 630.9Pa in turn, while the G' and G" of the gel did not change significantly. The results showed that a slight change in the solvent would lead to a significant change in the mechanical strength of the gel.
凝胶的力学强度和粘弹性与胶凝剂的浓度密切相关,因此发明人还研究了实施例9、15、16中浓度效应对形成的可逆共价键分子凝胶的流变学性能的影响,结果见图7。由图7可见,四羟基修饰的双脲类化合物b的浓度分别为0.036g/mL(实施例15)、0.040g/mL(实施例9)和0.045g/mL(实施例16)时,所得凝胶的屈服值依次为223.8Pa、777.0Pa、6010.2Pa,表明凝胶的力学强度随胶凝剂浓度的升高而增强。The mechanical strength and viscoelasticity of the gel are closely related to the concentration of the gelling agent, so the inventors also studied the effect of the concentration in Examples 9, 15, 16 on the rheological properties of the formed reversible covalent molecular gels. , and the results are shown in Figure 7. As can be seen from Figure 7, when the concentrations of the tetrahydroxy-modified diurea compound b were 0.036 g/mL (Example 15), 0.040 g/mL (Example 9) and 0.045 g/mL (Example 16), respectively, the obtained The yield value of the gel is 223.8Pa, 777.0Pa, 6010.2Pa in turn, indicating that the mechanical strength of the gel increases with the increase of the gelling agent concentration.
实施例17Example 17
基于实施例8的可逆共价键分子凝胶为基质检测汞离子Detecting mercury ions based on the reversible covalent molecular gel of Example 8 as a matrix
1、将0.04g(0.092mmol)四羟基修饰的双脲类化合物b溶于330μL二甲亚砜中,超声至溶液澄清,然后加入570μL 0.1g/mL(0.092mmol)硼酸的二甲亚砜溶液、100μL含3.7mg(0.092mmol)氢氧化钠和1.26mg(1.5×10-3mmol)氯金酸的水溶液,混合均匀,常温避光静置15分钟,得到含有氯金酸的无色凝胶。1. Dissolve 0.04g (0.092mmol) of tetrahydroxy-modified diurea compound b in 330μL of dimethyl sulfoxide, sonicate until the solution is clear, and then add 570μL of 0.1g/mL (0.092mmol) boric acid in dimethyl sulfoxide solution , 100 μL of an aqueous solution containing 3.7 mg (0.092 mmol) of sodium hydroxide and 1.26 mg (1.5 × 10 -3 mmol) of chloroauric acid, mixed well, and allowed to stand for 15 minutes at room temperature in the dark to obtain a colorless gel containing chloroauric acid .
2、在含有氯金酸的无色凝胶上加入250μL体积浓度为88%的水合肼的无水乙醇溶液,将瓶口封好,室温避光放置24小时,得到含有纳米金颗粒的紫色凝胶。由图8可见,所得凝胶中金颗粒的平均粒径为20~30nm。2. Add 250 μL of 88% hydrazine hydrate solution in absolute ethanol to the colorless gel containing chloroauric acid, seal the bottle, and place it in the dark at room temperature for 24 hours to obtain a purple gel containing gold nanoparticles. glue. It can be seen from FIG. 8 that the average particle size of the gold particles in the obtained gel is 20-30 nm.
3、将含有纳米金颗粒的凝胶上部剩余的水合肼的无水乙醇溶液倒掉,然后加入150μL超纯水将凝胶破坏,再加入350μL二甲亚砜使溶液澄清透明,得到凝胶和纳米金的复合溶液,采用紫外-可见分光光度计测定该复合溶液的表面等离子共振吸收峰λ0,再分别加入浓度为1、2、3…18、19、20μmol/L的氯化汞水溶液,采用紫外-可见分光光度计测定不同浓度汞离子对应体系的表面等离子共振吸收峰λ,结果见图9,并绘制Δλ随汞离子浓度变化的标准曲线,其中Δλ=λ0-λ,结果见图10。3. Pour off the remaining hydrazine hydrate solution in absolute ethanol on the top of the gel containing gold nanoparticles, then add 150 μL of ultrapure water to destroy the gel, and then add 350 μL of dimethyl sulfoxide to make the solution clear and transparent to obtain gel and The composite solution of nano-gold, the surface plasmon resonance absorption peak λ 0 of the composite solution was measured by ultraviolet-visible spectrophotometer, and then mercuric chloride aqueous solutions with concentrations of 1, 2, 3...18, 19, 20 μmol/L were added respectively, The surface plasmon resonance absorption peak λ of the corresponding system with different concentrations of mercury ions was measured by UV-visible spectrophotometer, the results are shown in Figure 9, and the standard curve of Δλ with the concentration of mercury ions was drawn, where Δλ=λ 0 -λ, the results are shown in Figure 9 10.
由图9可见,随着汞离子浓度的增加,表面等离子共振吸收峰呈现蓝移,吸收强度略有增加,在556nm处观察到等消光点。由图10可见,当汞离子在较低浓度范围内(0~6μmol/L)时,Δλ与汞离子浓度呈线性关系,线性方程为:Y=0.07143+2X,其中Y代表Δλ,X为汞离子浓度,其相关系数R=0.9977。根据S/N=3计算出该方法的检出限为0.2μmol/L。It can be seen from Figure 9 that with the increase of mercury ion concentration, the surface plasmon resonance absorption peak exhibits a blue shift, the absorption intensity increases slightly, and an iso-extinction point is observed at 556 nm. It can be seen from Figure 10 that when the mercury ion concentration is in the lower concentration range (0-6 μmol/L), Δλ has a linear relationship with the mercury ion concentration. The linear equation is: Y=0.07143+2X, where Y represents Δλ, and X is mercury Ion concentration, its correlation coefficient R=0.9977. According to S/N=3, the detection limit of this method was calculated to be 0.2 μmol/L.
4、按照上述步骤3的方法用紫外-可见分光光度计测量待测样品对应体系的表面等离子共振吸收峰λ,根据公式Δλ=λ0-λ,计算待测样品对应的Δλ,结合标准曲线的线性方程即可高选择性识别汞离子并确定待测样品中汞离子的浓度。4. According to the method of
发明人按照表1所示,考察了实施例17中四羟基修饰的双脲类化合物b、硼酸、氢氧化钠对汞离子(6μmol/L)检测结果的影响,实验结果见图11。As shown in Table 1, the inventors investigated the effects of the tetrahydroxy-modified diurea compound b, boric acid, and sodium hydroxide on the detection results of mercury ions (6 μmol/L) in Example 17. The experimental results are shown in Figure 11 .
表1对照实验Table 1 Control experiment
注:表中“-”表示不含所在单元格中的物质,“√”表示含有所在单元格中的物质。Note: "-" in the table means not containing the substance in the cell, and "√" means containing the substance in the cell.
实验结果显示,本发明检测汞离子的方法中,四羟基修饰的双脲类化合物b、硼酸、氢氧化钠这三种物质缺一不可,表明本发明可逆共价键分子凝胶在汞离子的检测过程中扮演了重要的角色。The experimental results show that in the method for detecting mercury ions of the present invention, tetrahydroxy-modified diurea compounds b, boric acid and sodium hydroxide are indispensable, indicating that the reversible covalent bond molecular gel of the present invention is in the presence of mercury ions. played an important role in the detection process.
为了证明本发明的有益效果,发明人采用实施例17的方法分别对环境中的其他金属离子如铁离子、铬离子、镁离子、钴离子、钡离子、镍离子、钙离子、镉离子、铅离子、锌离子、铜离子的水溶液进行检测。实验结果表明,即使将铁离子、铬离子、镁离子、钴离子、钡离子、镍离子、钙离子、镉离子、铅离子、锌离子、铜离子的浓度增加至100μmol/L,体系的颜色也不发生任何变化,而汞离子浓度为6μmol/L时,体系的颜色马上由原来的紫色变为红色(见图12),说明该方法可实现汞离子的选择性检测。In order to prove the beneficial effect of the present invention, the inventor adopts the method of Example 17 to treat other metal ions in the environment, such as iron ion, chromium ion, magnesium ion, cobalt ion, barium ion, nickel ion, calcium ion, cadmium ion, lead ion, respectively. Aqueous solutions of ions, zinc ions, and copper ions are used for detection. The experimental results show that even if the concentration of iron ion, chromium ion, magnesium ion, cobalt ion, barium ion, nickel ion, calcium ion, cadmium ion, lead ion, zinc ion, and copper ion is increased to 100 μmol/L, the color of the system will not change. No change occurred, and when the mercury ion concentration was 6 μmol/L, the color of the system immediately changed from the original purple to red (see Figure 12), indicating that this method can realize the selective detection of mercury ions.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710832006.9A CN107674003B (en) | 2017-09-15 | 2017-09-15 | Tetrahydroxy-modified diurea compounds and their gels and gel-based methods for detecting mercury ions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710832006.9A CN107674003B (en) | 2017-09-15 | 2017-09-15 | Tetrahydroxy-modified diurea compounds and their gels and gel-based methods for detecting mercury ions |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107674003A CN107674003A (en) | 2018-02-09 |
CN107674003B true CN107674003B (en) | 2020-02-21 |
Family
ID=61136923
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710832006.9A Active CN107674003B (en) | 2017-09-15 | 2017-09-15 | Tetrahydroxy-modified diurea compounds and their gels and gel-based methods for detecting mercury ions |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107674003B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110483734B (en) * | 2019-08-27 | 2021-05-28 | 山东益丰生化环保股份有限公司 | Polyurethane optical resin material with high softening temperature, high impact toughness and yellowing resistance and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RO82996A2 (en) * | 1982-02-05 | 1984-01-14 | Combinatul Petrochimic "Solventul",Ro | RIGID POLYURETHANE FOAM AND PROCESS FOR OBTAINING |
JPH0790208A (en) * | 1993-09-21 | 1995-04-04 | Canon Inc | Water-based pigment ink and method for ink-jet recording using the same |
JPH07268261A (en) * | 1994-03-30 | 1995-10-17 | Canon Inc | Recording fluid, ink jet recording method using the same, and apparatus using the same |
-
2017
- 2017-09-15 CN CN201710832006.9A patent/CN107674003B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RO82996A2 (en) * | 1982-02-05 | 1984-01-14 | Combinatul Petrochimic "Solventul",Ro | RIGID POLYURETHANE FOAM AND PROCESS FOR OBTAINING |
JPH0790208A (en) * | 1993-09-21 | 1995-04-04 | Canon Inc | Water-based pigment ink and method for ink-jet recording using the same |
JPH07268261A (en) * | 1994-03-30 | 1995-10-17 | Canon Inc | Recording fluid, ink jet recording method using the same, and apparatus using the same |
Non-Patent Citations (4)
Title |
---|
A Family of Hydrogels Based on Ureido-Linked Aminopolyol-Derived Amphiphiles and Bolaamphiphiles: Synthesis, Gelation under Thermal and Sonochemical Stimuli, and Mesomorphic Characterization;Martin Avalos等;《Chem. Eur. J.》;20080506;第14卷;5656-5669页 * |
Salt Tunable Rheology of Thixotropic Supramolecular Organogels and Their Applications for Crystallization of Organic Semiconductors;Sheng Gao等;《Langmuir》;20161030;12805-12813页 * |
Self-Assembly Studies of a Chiral Bisurea-Based Superhydrogelator;Francisco等;《Chem. Eur. J.》;20121227;第18卷;14725-14731页 * |
动态共价键诱导物理胶凝化;王酸酸等;《中国化学会第十六届胶体与界面化学会议》;20170724;131页 * |
Also Published As
Publication number | Publication date |
---|---|
CN107674003A (en) | 2018-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yin et al. | Ratiometric fluorescence sensing and real-time detection of water in organic solvents with one-pot synthesis of Ru@ MIL-101 (Al)–NH2 | |
Moon et al. | Diametrically disubstituted cyclam derivative having Hg2+-selective fluoroionophoric behaviors | |
CN102942537B (en) | Benzothiazole-aniline compound used as pH fluorescent probe and preparation method thereof | |
Zhang et al. | Novel Fe3+ fluorescence probe based on the charge-transfer (CT) molecules | |
CN100486976C (en) | Fluorescent molecular probe and use for inspecting transient metal and heavy metal ion | |
Liu et al. | Tetrathienylethene based red aggregation-enhanced emission probes: super red-shifted mechanochromic behavior and highly photostable cell membrane imaging | |
Wang et al. | A “Turn-On” fluorescent chemosensor with the aggregation-induced emission characteristic for high-sensitive detection of Ce ion | |
Alamiry et al. | Intramolecular excimer formation for covalently linked boron dipyrromethene dyes | |
Nishiyabu et al. | Dansyl-containing boronate hydrogel film as fluorescent chemosensor of copper ions in water | |
CN103214428A (en) | Benzothiazole-cyanophenyl compound serving as hydrazine fluorescence probe as well as preparation method and application method of benzothiazole-cyanophenyl compound | |
CN110156806B (en) | Copper ion ratio type fluorescent probe based on rhodamine derivatives, and preparation method and application thereof | |
Abdurahman et al. | Novel triazole-based AIE materials: Dual-functional, highly sensitive and selective fluorescence probe | |
CN106916591A (en) | A kind of carbon for launching white fluorescent is selected and its application in organic reagent is detected | |
CN105906624A (en) | Fluorescent compounds with sensing functions for anilines and o-toluidines, and preparation and application of fluorescent sensing film of fluorescent compounds | |
Elmasry et al. | Ultrasensitive detection and removal of carbamazepine in wastewater using UCNPs functionalized with thin-shell MIPs | |
Zhao et al. | A highly emissive cruciform triarylborane as a ratiometric and solid state fluorescence sensor for fluoride ions | |
Yan et al. | Quantitative and rapid detection of explosives using an efficient luminogen with aggregation-induced emission characteristics | |
Cao et al. | Complexation between Pentiptycene Derived Bis (crown ether) s and CBPQT4+ Salt: Ion-Controlled Switchable Processes and Changeable Role of the CBPQT4+ in Host− Guest Systems | |
CN107245334A (en) | A kind of water soluble polymer fluoresceins fluorescence probe for detecting mercury ion and preparation method thereof | |
CN106432178A (en) | Nitric oxide probe based on fluorescence 'double response' mechanism and synthesis and application thereof | |
Sivamani et al. | Self-assembly,“turn-on” fluorescent detection of fluoride ion using uracil based azo derivatives and their application in imaging of living cells | |
Jang et al. | Micellization-induced amplified fluorescence response for highly sensitive detection of heparin in serum | |
WO2011137574A1 (en) | Fluoride-boron dye fluorescent probe for detecting mercury ion | |
David et al. | N-Arylated bisferrocene pyrazole for the dual-mode detection of hydrogen peroxide: an AIE-active fluorescent “turn ON/OFF” and electrochemical non-enzymatic sensor | |
CN107674003B (en) | Tetrahydroxy-modified diurea compounds and their gels and gel-based methods for detecting mercury ions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |